CIK 0001566044 · Non-accelerated filer<br>Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453757789
- Phone
- (203) 433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-30 | Zeronda Tyler CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −84 | $1.88 | $158 | 131,567 |
| 2024-09-30 | Stuart Iain CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −109 | $1.88 | $205 | 133,494 |
| 2024-09-30 | Harsch Mutya CHIEF LEGAL OFFICER AND GC | Shares withheld for taxes | −105 | $1.88 | $197 | 149,026 |
| 2024-09-30 | Domzalski David PRESIDENT AND CEO | Shares withheld for taxes | −685 | $1.88 | $1K | 496,696 |
| 2024-07-01 | Zeronda Tyler CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −92 | $1.92 | $177 | 131,651 |
| 2024-07-01 | Stuart Iain CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −138 | $1.92 | $265 | 133,603 |
| 2024-07-01 | Harsch Mutya CHIEF LEGAL OFFICER AND GC | Shares withheld for taxes | −143 | $1.92 | $275 | 149,131 |
| 2024-07-01 | Domzalski David PRESIDENT AND CEO | Shares withheld for taxes | −935 | $1.92 | $2K | 497,654 |
| 2024-05-31 | Domzalski David PRESIDENT AND CEO | Grant or award | +4,429 | $2.16 | $10K | 498,589 |
| 2024-04-01 | Zeronda Tyler CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −94 | $3.08 | $290 | 131,743 |
| 2024-04-01 | Stuart Iain CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −157 | $3.08 | $484 | 133,741 |
| 2024-04-01 | Harsch Mutya CHIEF LEGAL OFFICER AND GC | Shares withheld for taxes | −161 | $3.08 | $496 | 149,274 |
| 2024-04-01 | Domzalski David PRESIDENT AND CEO | Shares withheld for taxes | −1,004 | $3.08 | $3K | 494,160 |
| 2024-01-02 | Zeronda Tyler Chief Financial Officer | Shares withheld for taxes | −93 | $2.28 | $212 | 131,837 |
| 2024-01-02 | Stuart Iain Chief Scientific Officer | Shares withheld for taxes | −157 | $2.28 | $358 | 133,898 |
| 2024-01-02 | Harsch Mutya Chief Legal Officer and GC | Shares withheld for taxes | −161 | $2.28 | $367 | 149,435 |
| 2024-01-02 | Domzalski David President and CEO | Shares withheld for taxes | −1,004 | $2.28 | $2K | 495,164 |
| 2024-01-01 | Zeronda Tyler Chief Financial Officer | Grant or award | +62,500 | 131,930 | ||
| 2024-01-01 | Zeronda Tyler Chief Financial Officer | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2024-01-01 | Stuart Iain Chief Scientific Officer | Grant or award | +62,500 | 134,055 |
Page 4 of 6 · 113 trades